Effect of Omega-3 Supplementation on Lipid Profile in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Publisher Pubmed



Khorshidi M^{1, 2} ; Hazaveh ZS³ ; Alimohammadikamalabadi M⁴ ; Jamshidi S² ; Moghaddam OM⁵ ; Olang B¹ ; Hatefi S¹ ; Hosseini A¹ ; Jamilian P⁶ ; Zarezadeh M^{7, 8} ; Kohansal P⁹ ; Heshmati J¹⁰ ; Jamilian P⁶ ; Sayyari A^{1, 12} Show Affiliations
Source: Nutrition Journal Published:2023

Abstract

Purpose: Dyslipidemia is considered as a known risk factor for cardiovascular disease. Yet various trials with wide ranges of doses and durations have reported contradictory results. We undertook this meta-analysis of randomized controlled trials (RCTs) to determine whether omega-3 supplementation can affect lipid profile in children and adolescents. Methods: Cochrane Library, Embase, PubMed, and Scopus databases were searched up to March 2021. Meta-analysis was performed using random-effect method. Effect size was expressed as weighted mean difference (WMD) and 95% confidence interval (CI). Heterogeneity was assessed using the I2 index. In order to identification of potential sources of heterogeneity, predefined subgroup and meta-regression analysis was conducted. Results: A total of 14 RCTs with 15 data sets were included. Based on the combination of effect sizes, there was a significant reduction in TG levels (WMD: -15.71 mg/dl, 95% CI: -25.76 to -5.65, P=0.002), with remarkable heterogeneity (I2=88.3%, P<0.001). However, subgroup analysis revealed that omega-3 supplementation significantly decreased TG only in studies conducted on participants ≤13 years old (WMD=-25.09, 95% CI: -43.29 to -6.90, P=0.007), (I2=84.6%, P<0.001) and those with hypertriglyceridemia (WMD=-28.26, 95% CI: -39.12 to -17.41, P<0.001), (I2=0.0%, P=0.934). Omega-3 supplementation had no significant effect on total cholesterol, HDL, and LDL levels. Also, results of nonlinear analysis showed significant effect of treatment duration on HDL status (Pnon-linearity=0.047). Conclusion: Omega-3 supplementation may significantly reduce TG levels in younger children and those with hypertriglyceridemia. Also, based on the HDL-related results, clinical trials with longer duration of intervention are recommended in this population. © 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.